153 related articles for article (PubMed ID: 27267495)
1. Antithyroid Drugs-The Most Common Treatment for Graves' Disease in the United States: A Nationwide Population-Based Study.
Brito JP; Schilz S; Singh Ospina N; Rodriguez-Gutierrez R; Maraka S; Sangaralingham LR; Montori VM
Thyroid; 2016 Aug; 26(8):1144-5. PubMed ID: 27267495
[No Abstract] [Full Text] [Related]
2. [Graves' disease and liver abnormalities: antithyroid drugs are not the only factors involved!].
Zabulon A; Gelu-Simeon M; Bélia L; Chingan V; Duflo S; Vélayoudom-Céphise FL
Presse Med; 2015 Jan; 44(1):110-2. PubMed ID: 25530575
[No Abstract] [Full Text] [Related]
3. Changes of serum cytokines in hyperthyroid Graves' disease patients at diagnosis and during methimazole treatment.
Pedro AB; Romaldini JH; Takei K
Neuroimmunomodulation; 2011; 18(1):45-51. PubMed ID: 20628263
[TBL] [Abstract][Full Text] [Related]
4. Influence of thyroid volume on the effect of methimazole in Japanese subjects with mild Graves' disease.
Kimura T; Matsuki M; Kaneto H; Mune T; Kaku K
Eur J Intern Med; 2016 Dec; 36():e31-e32. PubMed ID: 27601286
[No Abstract] [Full Text] [Related]
5. A 6-year follow-up of a randomized prospective trial comparing methimazole treatment with or without exogenous L-thyroxine in Chinese patients with Graves' disease.
Liu X; Qiang W; Liu X; Liu L; Liu S; Gao A; Gao S; Shi B
Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):564-7. PubMed ID: 25140995
[TBL] [Abstract][Full Text] [Related]
6. Predicting the Risk of Recurrence Before the Start of Antithyroid Drug Therapy in Patients With Graves' Hyperthyroidism.
Vos XG; Endert E; Zwinderman AH; Tijssen JG; Wiersinga WM
J Clin Endocrinol Metab; 2016 Apr; 101(4):1381-9. PubMed ID: 26863422
[TBL] [Abstract][Full Text] [Related]
7. Effects of chronic iodine administration on thyroid status in euthyroid subjects previously treated with antithyroid drugs for Graves' hyperthyroidism.
Roti E; Gardini E; Minelli R; Bianconi L; Salvi M; Gavaruzzi G; Braverman LE
J Clin Endocrinol Metab; 1993 Apr; 76(4):928-32. PubMed ID: 7682562
[TBL] [Abstract][Full Text] [Related]
8. Antithyroid drug treatment prior to radioiodine therapy for Graves' disease: yes or no?
Bogazzi F; Martino E; Bartalena L
J Endocrinol Invest; 2003 Feb; 26(2):174-6. PubMed ID: 12739747
[No Abstract] [Full Text] [Related]
9. [Graves' disease].
Radetti G; Rigon F; Tatò L; Tonini G; Bernasconi S; Bona G; Bozzola M; Buzi F; de Santis C; De Sanctis V
Minerva Pediatr; 1997 Nov; 49(11):545-7. PubMed ID: 9549300
[No Abstract] [Full Text] [Related]
10. Remission of Graves' hyperthyroidism treated with methimazole.
Bolaños F; González-Ortiz M; Durón H; Sánchez C
Rev Invest Clin; 2002; 54(4):307-10. PubMed ID: 12415954
[TBL] [Abstract][Full Text] [Related]
11. Soluble intercellular adhesion molecule-1 and Graves' disease.
Escobar-Morreale HF; Serrano J; Sancho JM; Varela C
Thyroid; 1997 Oct; 7(5):801-3. PubMed ID: 9349588
[No Abstract] [Full Text] [Related]
12. [Effect of thyroxine upon prevention of recurrence of Graves' disease treated with antithyroid drugs].
Wu G; Jie Y; Situ Y
Zhonghua Yi Xue Za Zhi; 2001 Mar; 81(5):274-5. PubMed ID: 11798886
[TBL] [Abstract][Full Text] [Related]
13. Antithyroid drugs in the management of patients with Graves' disease: an evidence-based approach to therapeutic controversies.
Cooper DS
J Clin Endocrinol Metab; 2003 Aug; 88(8):3474-81. PubMed ID: 12915620
[No Abstract] [Full Text] [Related]
14. Frequency of antineutrophil cytoplasmic antibody in Graves' disease patients treated with methimazole.
Gumà M; Salinas I; Reverter JL; Roca J; Valls-Roc M; Juan M; Olivé A
J Clin Endocrinol Metab; 2003 May; 88(5):2141-6. PubMed ID: 12727967
[TBL] [Abstract][Full Text] [Related]
15. Migratory polyarthritis as an adverse effect of thiamazole use in a 13-year-old girl with Graves' disease.
Janson JA; de Laat P; Draaisma JM
J Pediatr Endocrinol Metab; 2015 Sep; 28(9-10):1169-71. PubMed ID: 25968432
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy of chloroquine and methimazole in Graves' disease: a pilot randomized controlled trial.
Soltani A; Moayyeri A; Azizi F
Biomed Pharmacother; 2007 May; 61(4):241-3. PubMed ID: 17462854
[No Abstract] [Full Text] [Related]
17. Preventing Graves' ophthalmopathy.
Wiersinga WM
N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
[No Abstract] [Full Text] [Related]
18. Antithyroid drugs inhibit radioiodine-induced increases in thyroid autoantibodies in hyperthyroid Graves' disease.
Nakazato N; Yoshida K; Mori K; Kiso Y; Sayama N; Tani JI; Nakagawa Y; Ito S
Thyroid; 1999 Aug; 9(8):775-9. PubMed ID: 10482369
[TBL] [Abstract][Full Text] [Related]
19. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
20. Hypothyroidism during antithyroid drug treatment with methimazole is a favorable prognostic indicator in patients with Graves' disease.
Choo YK; Yoo WS; Kim DW; Chung HK
Thyroid; 2010 Sep; 20(9):949-54. PubMed ID: 20629556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
